Robledo Kristy P, Libesman Sol, Yelland Lisa Nicole
NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia
NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia.
Arch Dis Child Fetal Neonatal Ed. 2025 Jun 19;110(4):362-368. doi: 10.1136/archdischild-2024-327983.
To conduct a methodological systematic review of multicentre trials of premature infants to (1) determine if and how multiple births have been considered in the design, analysis and reporting of recent trials and (2) assess whether there has been an improvement since the last review was conducted 10 years ago.
A systematic search was conducted in PubMed on 28 June 2023 for articles published between June 2018 and June 2023. Articles were eligible for inclusion if they were a multicentre randomised trial of infants born preterm and reported the results of a primary outcome that was measured on an infant or could be attributed to an infant.
We reviewed 62/74 trials (80%), after determining it was unclear if multiple births were present in the other 20%. 87% of trials (54/62) did not account for multiple births in their sample size calculations and 48% (30/62) did not account for clustering due to multiple births in their analyses. Problems were not limited to lower-ranked journals. No trials reported the intraclass correlation coefficient for any outcomes, indicating the degree of clustering present.
Persistent problems remain with the design and analysis of multicentre trials of premature infants due to ignoring the complexity that comes with the inclusion of multiple births, despite methods available to address this. Trialists should consider the impact of multiple births in their trial design and analysis. Readers of neonatal trials should be aware of these issues, particularly those who peer review papers.
对早产儿多中心试验进行方法学系统评价,以(1)确定近期试验在设计、分析和报告中是否以及如何考虑多胞胎情况,(2)评估自10年前上次综述以来是否有改进。
于2023年6月28日在PubMed上进行系统检索,查找2018年6月至2023年6月发表的文章。如果文章是关于早产儿的多中心随机试验,并报告了在婴儿身上测量的主要结局结果或可归因于婴儿的主要结局结果,则符合纳入标准。
在确定另外20%的试验中是否存在多胞胎情况不明确后,我们对74项试验中的62项(80%)进行了综述。87%的试验(54/62)在样本量计算中未考虑多胞胎情况,48%(30/62)在分析中未考虑因多胞胎导致的聚类情况。问题并不局限于排名较低的期刊。没有试验报告任何结局的组内相关系数,该系数表明存在的聚类程度。
尽管有方法可解决这一问题,但由于忽视了纳入多胞胎带来的复杂性,早产儿多中心试验的设计和分析仍存在持续问题。试验者应在试验设计和分析中考虑多胞胎的影响。新生儿试验的读者应意识到这些问题,尤其是那些同行评审论文的读者。